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The objective of this study was to develop spirometric reference equations for healthy, never-smoking, older 
adults. It was designed as a cross-sectional observational study consisting of 1510 Seventh Day Adventists, ages 
43-79 years enrolled in a study of health effects of air pollutants. Individuals were excluded from the reference group 
(n=565) for a history of current respiratory illness, smoking, or chronic respiratory disease, and for a number 
of ‘non-respiratory’ conditions which were observed in these data to be related to lower values of FEV,. 
Gender-specific reference equations were developed for the entire reference group and for a subset above 65 years of 
age (n= 312). Controlling for height and age, lung function was found to be positively related to the difference 
between armspan and height, and in males was found to be quadratically related to age. The predicted values for 
this population generally fell within the range of those of other population groups containing large numbers of 
adults over the age of 65 years. Individuals with lung function below the 5th percentile in this sample, however, could 
not be reliably identified by using the lower limits of normal predictions commonly used in North America and 
Europe. 
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Introduction 
Many of the reference equations commonly used for 
prediction of normal spirometric values in Europe and 
North America have been derived from studies which 
included relatively small numbers of individuals over the 
age of 65 years. Consequently, predicted values for older 
individuals are often based upon few observations or upon 
extrapolations. In contrast, Enright et al. (1) have recently 
derived spirometric prediction equations from a reference 
population of 777 ‘healthy’ never-smoking individuals ages 
65-85 years and compared their predictions for this age 
group with predicted values from several other studies (2-5) 
which are the source of reference equations used in most 
North American teaching hospitals (6). They found reason- 
ably large differences among these studies in predicted 
values for this age group and concluded that use of these 
reference equations may lead to inaccurate interpretations 
of spirometric tests for individuals over the age of 65 years. 
Furthermore, they identified several relatively common 
‘non-respiratory’ medical conditions which they found to 
be associated with FEV, and which they used as exclusion 
criteria for the selection of the reference population from 
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which they derived prediction equations for normal lung 
function. 
The purpose of this paper is to describe spirometric 
reference equations for a cohort of ‘healthy’ never-smoking 
adults with large numbers of subjects above 65 years of age 
and to compare the predicted values of this sample with 
those from three other studies. We selected for comparison 
the study of Enright et al. (1) with a large cohort of subjects 
ages 65-85 years, European summary predictions (7) rec- 
ommended for use up to age 70 years, and a large popula- 
tion based study (5) with a number of subjects above the 
age of 65 years. Secondary purposes included identification 
of ‘non-respiratory’ medical conditions which were associ- 
ated with lower lung function and exploration of the 
relationships between lung function and the difference 
between armspan and height in adults. 
Methods 
SUBJECTS 
Study participants were from a cohort followed since 1977 
in the Adventist Health Air Pollution (AHSMOG) study 
(8). All members of the Seventh Day Adventist Church over 
25 years of age in 1976 residing within a 5 mile radius 
for the previous 11 years in the Los Angeles, San Diego, 
and San Francisco metropolitan areas were recruited. 
A 10% sample of those with similar characteristics who 
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lived elsewhere in California were also recruited. Of those 
eligible, 7445 individuals enrolled in the AHSMOG study 
in 1977. In spring 1993, all 1729 individuals less than 
80 years, who completed questionnaires in 1977, 1987 
and 1992, without prior chest surgery or recent cardiac 
events, living and working within 20 miles of air quality 
monitoring stations in California, were invited to have lung 
function testing. The refusal rate was 3.6%. Spirometry was 
performed in 1510 (87%) of those eligible. 
MEDICAL HISTORY AND PHYSICAL 
CHARACTERISTICS 
Subjects completed an extensive self-administered mail 
health and exposure questionnaire in spring 1992. At the 
time of spirometry in 1993 a structured interview obtained 
information on demographic factors, recent exposures, 
recent illness, and medications used, and participants 
brought in all their current medications, A more compre- 
hensive written questionnaire was also completed updating 
health, activity, and exposure information; inconsistencies 
with answers in 1992 were resolved immediately by personal 
interview. Technicians measured height (HT) without shoes 
(nearest 0.25 inch), weight (nearest pound), and armspan 
(ARM) with participants standing with backs against a wall 
(nearest 0.25 inch). Measures were then converted to metric 
units. 
LUNG FUNCTION - TRAINING, PERFORMANCE 
AND ACCEPTABILITY 
Spirometry was conducted by four Registered Respiratory 
Therapists after 12 h of initial training conducted by an 
author (P.E.) using the Cardiovascular Health Study 
Pulmonary Function Testing Manual of Operations (1). 
Complete testing on 30 pilot subjects was conducted and 
performance was evaluated for acceptability for each tech- 
nician prior to the study. The quality of tracings with 
regard to both flow and volume measurements and com- 
pliance with ATS guidelines (9) were evaluated weekly by 
an external consultant team, and results were communi- 
cated to the field supervisor and each technician. Perform- 
ance trends were monitored to maintain the highest quality 
of testing. Technicians were retrained as necessary. 
Technicians demonstrated and instructed participants in 
performance of slow vital capacity (SVC) and forced vital 
capacity (FVC) maneuvers. Participants completed expira- 
tory SVC maneuvers (holding their noses) until two accept- 
able ones within 5% of each other were obtained. Up to 
eight FVC maneuvers were performed without noseclips 
until three acceptable ones with the two largest FEV,s 
within 5% were recorded, as per ATS (9). Subjects were 
sitting unless their BMI exceeded 30 kg m ~ ‘. Each flow- 
volume curve was examined by the technician and checked 
by computer algorithm for coughs, poor efforts, and other 
evidence of improper performance. 
EQUIPMENT, CALIBRATION, AND PROCESSING 
Spirometry data were collected and processed using three 
identical, new rolling seal spirometers connected to laptop 
computers with existing software (S&M Instruments, 
Doylestown, PA, U.S.A.). This system had been found to 
meet ATS standards (10). Calibration was checked daily 
using a 3 1 syringe, and leak tests were performed on each 
spirometry system. Spirometer temperature was recorded 
continuously by thermistor built into the spirometer bell, 
and the temperature measured at end expiration was used 
in gas volume calculations. Barometric pressure, measured 
daily, permitted conversion of results to body tempera- 
ture and pressure, saturated (BTPS). Time zero of each 
maneuver used the back-extrapolation technique (9). The 
largest FVC and FEV, were selected from the three accept- 
able maneuvers and the FEF,,-,, was selected from the 
maneuver with the highest sum of FVC and FEV, (9). 
The FEV, as a percentage of FVC was calculated using the 
largest values of FEV, and FVC. The maximum of all FVC 
and SVC (MVC) was used for calculation of FEV,/MVC. 
STATISTICAL ANALYSIS 
A never-smoking, ‘healthy’ reference group was selected 
for developing lung function reference equations. First 
excluded from the overall sample were those with chronic 
respiratory diseases or congestive heart failure. Then, 
health factors potentially related to FEV, were identified, 
including use of medications, symptoms (e.g. respiratory 
illness on the day of testing, phlegm, and dyspnea) and 
personal characteristics (e.g. BMI, exposure to environ- 
mental tobacco smoke). These characteristics were tested 
for a significant relationship with FEV, in stepwise linear 
regression models controlling for age and height for each 
gender (11). Variables entering at/below P=O.lO for either 
gender were selected as exclusion criteria. All statistical 
analyses utilized SPSS version 6.1 for Windows 3.1. 
Reference equations for FVC, FEV,, FEF2,; 75, FEV,/ 
FVC, MVC, and FEV,/MVC were generated for each 
gender using multiple linear regression with AGE, height 
(HT), AH (defined as ‘excess’ armspan or ARM minus 
HT), their crossproduct terms, AGE2 and AGE3 used as 
independent variables. (Preliminary multiple regression 
analysis of the FEV, data indicated that neither BMI, 
BMI’, HT2, AH’, nor their crossproduct terms were 
associated with FEV, in either gender.) Those variables 
entering at P<O.O5 were selected for the best fitting model. 
Regression diagnostics identified, for exclusion, up to three 
observations for each gender whose residual (observed- 
predicted) values were more than three standard deviations 
from zero. Independent variables were centered (i.e. the 
variable mean was subtracted from each observed value) in 
the regressions for selection of the best model in order to 
reduce collinearity among higher order and cross-product 
terms. 
For comparison with other reference equations, models 
were fit with only age and height as independent variables 
for the entire reference group and also for the subset of 
individuals above the age of 65 years. Quantities, referred 
to here as the lower limits of normal (LLN), were calculated 
from the frequency distributions of residuals (4) assuming 
homoscedasticity and with inclusion of the outliers. Sub- 
traction of the LLN from the predicted values gives the 
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TABLE 1. Conditions associated with low FEV, 
Females Males 
B (SE) n (P> P (SE) n m 
Diuretics 
/?-blockers 
Digitalis 
Diabetes medications 
Dyspnea 
Cold/sinus 
Low BMI 
- 0.114 (0.039) 76 (0.003) - 0.115 (0.097) 21 (0.24) 
- 0.094 (0.046) 54 (0.04) +0.079 (0.104) 17 (0.45) 
- 0.132 (0.074) 20 (0.07) +0.188 (0.143) 9 (0.19) 
- 0.073 (0.079) 16 (0.36) - 0.203 (0.106) 17 (0.06) 
- 0.151 (0.047) 48 (0.001) - 0.125 (0.178) 6 (0.48) 
- 0.004 (0.047) 47 (0.94) - 0.235 (0.100) 19 (0.02) 
- 0.229 (0.099) 10 (0.02) - 0.106 (0.247) 3 (0.67) 
Regression coefficient p, effect on FEVI in I. n, number of subjects with condition. P, P-value for 
significance of p. Dyspnea, report of shortness of breath on exertion. Cold/sinus, current symptoms 
of upper respiratory or sinus infection. Low BMI, body mass index below the 5th percentile. 
TABLE 2. Characteristics of the reference population 
Females Males 
Number (n) 
n>65 years (%) 
n>75 years (%) 
Age (years) 
HT (cm) 
BMI (kg m-‘) 
AH (cm) 
ARM (cm) 
FEV, (1) 
FVC (1) 
FEV,/FVC (%) 
366 199 
195 (54%) 117 (59%) 
61 (17%) 37 (19%) 
64.3 f 9.4 (43-79) 65.5 zk 8.8 (4479) 
162 i 7 (142-178) 176 f 7 (159-192) 
25.8 z!z 4.1 (18.1-39.3) 26.7 h 3.6 (20.1-38.7) 
0.6 f 4.4 (- 13.3-12.7) 3.9 +z 5.3 (- 10.2-19.1) 
162 f 8.0 (137-185) 179 i 8.6 (152-202) 
2.36 f 0.48 (1.18-3.97) 3.31 zk 0.58 (2.14490) 
3.08 f 0.59 (1.55-5.00) 4.41-0.71 (2.87-6.12) 
76.7 f 6.0 (53.9-95.2) 75.4 zk 6.0 (58.9-90.2) 
HT, Height; BMI, body mass index; AH, armspan minus height; ARM, armspan; all measured 
variables are given as mean & SD (min-max). 
predicted lung function of the lower fifth percentile of the 18% older than 75 years. Overall, armspan was slightly 
reference population. larger than height in both genders (more in males). 
Results 
Spirometric testing was satisfactorily completed by 15 10 
subjects. Of these, 664 were initially excluded from the 
reference group for unacceptable spirometric tracings 
(0.5%) past history of smoking, chronic respiratory disease, 
current acute lower respiratory illness, or congestive heart 
failure. In these remaining (n=846), it was found that 
several conditions were negatively related (PcO.1) to FEV, 
in either gender (Table 1): present cold or sinus illness, 
dyspnea on exertion, BMI less than the fifth percentile, or 
use of beta-adrenergic blockers, diuretics, cardiac glyco- 
sides, or diabetes medications. We excluded the 28 1 subjects 
with these conditions, leaving 366 females and 199 males. 
Demographics, physical characteristics and lung function 
of the reference group are presented in Table 2. Over 50% 
of the sample was older than 65 years with approximately 
Most lung function measures were significantly positively 
associated with height and negatively associated with age 
[Table 3(a),(b)] for the entire reference group. Height was 
not significantly associated with FEVJFVC, FEV,/MVC 
or FEF,,_,, for males or with FEF25-75 for females. For 
lung function measures that had significant relations to 
other independent variables, alternate models containing all 
significant independent variables are presented in Table 4. 
For males, AGE* was observed to be significantly nega- 
tively related to FVC and MVC and explained an 
additional l-2% of the variance. A small negative, non- 
significant AGE2 coefficient was also observed for FVC 
@= - 0.0002, P=O.36) and MVC (D - 0.0002, P=O.32) for 
females. 
AH (armspan minus height) was found to be significantly 
positively related to FEV, in both genders (Table 4). A plot 
of running averages of residuals from the FEV, regressed 
on height and age against AH demonstrates increases 
in FEV, residuals with increasing AH [Fig. l(a),(b)]. 
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TABLE 3(a). Linear regression equations for lung function of adult males 
Constant HT Age r2 SEE LLN 
FEV, (1) - 1.508 (0,824) 0.0392 (0.0043)* - 0.03 14 (0.0032)* 0.55 0.384 0,583 
FVC (1) - 4.257 (1,021)* 0.0605 (0.0053)* - 0.0301 (0.0039)* 0.56 0.470 0.755 
MVC (1) - 4.593 (1,030)* 0.0621 (0.0053)* - 0.0286 (0.0039)* 0.56 0.474 0.752 
~ FEF,,~,, (1 s ‘) 3.768 (1,836)* 0.0158 (0.0095) - 0.0590 (0.007 l)* 0.30 0.852 1.180 
FEVJFVC (%) 101.3 (12.1)* - 0.070 (0.063) - 0,208 (0.047)* 0.09 5.7 8.6 
FEVJMVC (%) 105.7 (12.5)* - 0.090 (0.065) - 0,235 (0.048)* 0.11 5.8 9.4 
TABLE 3(b). Linear regression equations for lung function of adult females 
Constant HT 
FEV, 0) - 0.602 (0.491) 0.0287 (0.0027)* 
FVC (1) - 2.191 (0.604)* 0.0432 (0.0033)* 
MVC (1) - 1.970 (0.601)* 0.0419 (0.0033)* 
FEF,,-,, (1 s - ‘) 3.221 (1.016)* 0.0092 (0.0055) 
FEVJFVC (%) 119.3 (8.5)* - 0.184 (0.046)* 
FEVJMVC (%) 111.2 (8.4)* - 0.137 (0.046)* 
Age r2 SEE LLN 
- 0.0260 (0.0019)* 0.58 0.310 0.452 
- 0.0264 (0.0023)* 0.57 0.379 0.618 
- 0.0261 (0.0023)* 0.57 0.371 0.613 
- 0.0408 (0.0038)* 0.29 0.640 0.977 
- 0.196 (0.032)* 0.10 5.3 8.7 
- 0.200 (0.032)* 0.10 5.3 9.0 
HT, height in cm; Age in years, r, correlation coefficient; SEE, standard error of the estimate; LLN, quantity to be subtracted 
from the predicted value to give the 5th percentile value. Quantity in ( ) is SE of coefficient. 
TABLE 4. Alternate lung function regression equations 
Males 
FVC=4.464 (0.045)+0.0605 (0.0052) HT - 0.0343 (0.0042) Age - 0.00098 (0.00040) Age2 
MVC =4.5 16 (0.046) +0.062 1 (0,0053) HT - 0.0327 (0.0042) Age - 0.00097 (0.00040) Age* 
FEV, =3.308 (0.027)+0.0387 (0.0042) HT - 0.0316 (0.0032) Age+0.0103 (0.0052) AH 
Females 
FVC=3.084 (0.019)+0.0423 (0.0032) HT - 0.0267 (0.0022) Age+0.0156 (0.0045) AH - 0.0015 
(0.0006) HT x AH 
MVC=3.111 (0.019)+0.0411 (0.0032) HT - 0.0263 (0.0022) Age+0.0147 (0.0044) AH - 0.0015 
(0.0006) HT x AH 
FEV, =2.366 (0.016)+0.0290 (0.0027) HT - 0.0254 (0.0019) Age+0.0113 (0.0037) AH 
HT, height; AH, armspan minus height; lung function in 1; values in ( ) are SE of coefficients; note 
that the following variables were centered around the following mean values: males, age, 65.6 years; 
ht, 176 cm; AH, 3.9 cm; females, age, 64.5 years; ht, 162 cm; AH, 0.6 cm; all regression coefficients 
significant at WO.05. 
Additionally, the cross-product term HT x AH was signifi- within one standard deviation of the mean for each gender. 
cantly negatively related to both FVC and MVC in females Differences in the predictions ranged from - 4% to 5% for 
(Table 4). The coefficients of AH in males were positive and males and from - 3% to 3% in females. Furthermore, use 
of similar magnitude to the females for FVC @0.0127) of the predicted lower limits of normal for FEV, based 
and MVC (p=O.O109), though not significant. Overall, AH upon the full reference group resulted in identification of 
accounted for l-2”/0 of the variance beyond that explained 6.5% of males and 5.4% of females over the age of 65 years 
by age and height. as being below the 5th percentile. 
For the subset of individuals over 65 years, FEV, and 
FVC were significantly positively related to HT and nega- 
tively related to AGE (Table 5). Although, the coefficients 
for HT were smaller and those for AGE were more negative 
for the elderly group compared to the overall group, the 
predictions from the two sets of equations were, in general, 
similar for age between 65 and 80 years and for height 
Discussion 
These analyses have identified equations for predicting 
‘normal’ lung function values in a population of ‘healthy’, 
primarily older adults for subsequent analyses of airway 
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TABLE 5. Regression coefficients for adults ages 65-79 years 
Constant HT Age 
Females 
FEV, (1) 0.381 (0.701) 0.0250 (0.0034)* - 0.0314 (0.0051)* 
FVC (1) - 1.546 (0.848) 0.0409 (0.0041)* - 0.0304 (0.0062) 
FEVJFVC (%) 139.3 (12.9)* - 0.261 (0.063)* - 0.303 (0.095)* 
Males 
FEV, (1) 0.163 (1.250) 0.0360 (0.0054)* - 0.0469 (0.0088)* 
FVC (1) - 2.038 (1.563) 0.0571 (0.0068)* - 0.0528 (0.0107)* 
FEV,/FVC (%) 85.8 (19.0)* - 0.028 (0.083) - 0.096 (0.134) 
HT, height in cm; Age in years; quantity in ( ) is SE of coefficient; *P<O.O5. 
0.2 
0 
a 
0.1 - 0 
c -I 0 
m 3 0 0 0 
2 0 l 
g -0.1 
b 
3 
i -0.2 
0 
0 
-0.3 
Females 
-0.4 1 I I I I I I 
-15 -10 -5 0 5 10 15 20 
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0.2 , 
-15 -10 -5 0 5 10 15 20 
Armspan height (cm) 
FIG. 1. FEV, residuals from a model containing age and 
height vs the difference between armspan and height 
(AH). Each point is the average of all residuals falling 
within the 3 cm AH interval denoted by the midpoint of 
the interval. 
obstructive disease and have identified other factors that 
may be related to lung function in the elderly. As is 
traditional, individuals with symptoms or a history of 
respiratory disease or who previously smoked cigarettes 
were excluded from the reference.group. Because this was 
an older population, many individuals had other ‘non- 
respiratory’ medical illnesses. Several of these illnesses and 
use of certain medications were significantly (P<O. 1) related 
to a reduced level of FEV, in one/both genders (Table l), 
leading to further exclusions from the reference population. 
Factors related to a reduced FEV, included current 
respiratory infection which is known to reduce lung func- 
tion. Dyspnea on exertion could result from either pre- 
viously undiagnosed respiratory disease or congestive heart 
failure (CHF) resulting in loss of lung compliance. Use 
of diuretics, cardiac glycosides, or P-adrenergic blocking 
agents could indicate the presence of cardiovascular disease 
with effects upon the respiratory system or the presence of 
medication side-effects upon the respiratory system. Also, 
low BMI may be related to low lung function due to muscle 
weakness (5,12). The relationship between diabetes mellitus 
and lung function has been previously, if inconsistently, 
noted (1,13,14). These factors are generally similar to those 
identified by Enright et al. (1) in a study of older adults. 
Failure to exclude individuals with these conditions from 
the reference group results in lower predicted values and a 
lower probability of properly identifying otherwise healthy 
individuals who are being screened and who have lung 
function below the LLN. Failure to recognize that these 
factors may be related to low values of lung function could 
result in misinterpretation of the meaning of low lung 
function values in individuals with these conditions. 
Application of prediction equations derived from 
primarily younger adult populations to older adults may be 
inappropriate because the relationships between lung func- 
tion and age and height may change with age. Indeed, 
our data suggest that individuals above 65 years have a 
stronger, more negative relationship with age and a weaker 
positive relationship with height than do individuals less 
than 65 years. This is consistent with our observation 
(Table 5) that FVC was related to AGE2 and with obser- 
vations in several longitudinal studies (5,16) that loss of 
lung function may be accelerated in the elderly. We suspect 
that use of reference equations based primarily upon young 
adults, especially those still on the plateau between growth 
and decline of lung function, would result in overprediction 
of lung function in the elderly. On the other hand, 
our reference equations that are based upon adults ages 
43-79 years with the majority being above 65 years, 
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TABLE 6. A comparison of age and height coefficients for FEV, and FVC 
Study 
Females Males 
FEV, FVC FEV, FVC 
Age HT Age HT Age HT Age HT 
AHSMOG - 0.0260 0.0287 - 0.0264 0.0432 - 0.03 14 0.0392 - 0.0301 0.0605 
(ages 43379) 
AHSMOG - 0.0314 0.0250 - 0.0304 0.0409 - 0.0469 0.0360 - 0.0528 0.0571 
(ages 65579) 
Enright - 0.0325 0.028 1 - 0.0330 0.0365 - 0.0271 0.0378 - 0.0206 0.0567 
Quanjer - 0.025 0.0395 - 0.026 0.0443 - 0.029 0.0430 - 0.026 0.0576 
Morris - 0.025 0.0350 - 0.024 0.0453 - 0.032 0.0362 - 0.025 0.0583 
Crap0 - 0.0255 0.0342 - 0.0216 0.0491 - 0.0244 0.0414 - 0.02 14 0.0600 
Knudson - 0.021 0.027 - 0.022 0.037 - 0.027 0,052 - 0.029 0.065 
Age coefficients in 1 year ~ ‘. HT coefficients in 1 cm ~ ’ 
generally predicted lung function accurately for those 65579 
years and accurately identified those older adults below the 
5th percentile of lung function. 
With some exceptions, the relationships between lung 
function and age and height of the full reference group 
from this study were similar to those observed in other 
populations which included middle-aged and/or older 
adults (l-5,7) evidenced by the general similarity of linear 
regression coefficients for age and height (Table 6). The 
coefficients for our group of older females were more 
similar to those of Enright et al. (1) who only studied 
subjects above 65 years of age, than to the other studies 
which included younger individuals. The age coefficients of 
our admittedly small group of older males (n= 117), how- 
ever, were more negative than in any of the other studies. 
The predicted values of lung function at mean height 
(males= 176 cm, females= 162 cm) 11s age in the current 
study and those of Enright et al. (l), Quanjer et a/. (7), and 
Dockery et al. (5) were plotted. Some differences were seen 
(Fig. 2). For males age greater than 60 years, the predicted 
values of FEV,, FVC for the AHSMOG males are some- 
what higher. For females, the FVC and the FEV, values of 
AHSMOG and Enright et al. are similar and both are 
higher than those of Quanjer et al. and Dockery et al. The 
FEV,/FVC values were nearly identical for the AHSMOG 
and Quanjer studies for both genders, while those of 
Enright et al. were somewhat lower. 
Because prediction equations derived from cross- 
sectional data are primarily used as a screening tool to 
identify individuals with lung function below the expected 
range, the utility of any particular reference equation 
depends upon its ability to correctly identify individuals 
with lung function below some ‘lower limit of normal’ often 
defined as the 5th percentile of lung function for that 
population. As expected, the 5th percentile predictions 
from the full reference group for this study accurately 
identified those below the 5th percentile. The equations for 
the lower limits of normal from two of the above studies 
(5,7) identified only 0.3% and 0.8% of our participants as 
being below the 5th percentile, while the equations of 
Enright et al. (1) identified 5.4% of the females but none of 
the males in our study as being below the 5th percentile. 
While some of the differences among these studies in 
predicted mean and 5th percentile lung function values in 
the elderly may be due to inclusion of different age ranges, 
the effects of dissimilarity in underlying populations, 
measurement methods, and reference group exclusion 
criteria also play a large role. 
In addition to the above-described linear relationships 
between lung function and age and height, we observed a 
positive relationship between AH (‘excess’ armspan or the 
difference between armspan and height) and FEV, and 
FVC that explained an additional l-2% of the variance. 
Armspan is known to be correlated with both height and 
lung function (17-19) and has been used to calculate 
predicted values of lung function in individuals with 
deformities of the spine (18). Although spinal compression 
and its attendent reduction in height with advancing age 
may reduce thoracic cavity volume and lung function to 
some degree, prediction equations may underestimate lung 
function in those with reduced height due to spinal com- 
pression. Inclusion of the difference between armspan (an 
estimator of previous height) and current height as a 
predictor may correct for this underestimation. To some 
extent, the increased lung function related to AH could also 
be the result of a greater breadth of the thoracic cavity, 
some measures of which have been previously shown to be 
weakly related to lung function (19). On the other hand, 
individuals of a given height with longer arms would be 
expected to have longer limbs in general and, hence, a 
shorter torso, possibly resulting in decreased lung function. 
This would act to reduce the positive relationship between 
AH and lung function observed in this study. 
In conclusion, we developed reference equations for 
prediction of lung function of middle-aged and older 
adults. We found that lung function was related negatively 
to a number of ‘non-respiratory’ medical conditions and 
positively to the difference between armspan and height. 
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FIG. 2. Predicted values of lung function vs age for males and females from the AHSMOG population and three other 
populations (1,5,7). Predictions are for mean height for each gender (males, 176 cm; females, 162 cm). AHSMOG regres- 
sion lines are from Table 3. (- ), AHSMOG; (- - ), Enright; (. . .), Quanjer; (- ), Dockery. 
Although we found evidence that lung function was more those of a number of other cross-sectional studies of both 
strongly related to age and less strongly related to height in older and middle-aged adults. Differences among studies in 
those over 65 years of age compared to those less than 65 predictions of lung function or in identification of individ- 
years of age, the relationships between age and height in uals with lung function values below the 5th percentile may 
this primarily older population were generally similar to be due to differences in the age range of the reference 
subjects, but are also likely to be contributed to by differ- 
ences in exclusion criteria, different measurement methods, 
and other differences in the underlying populations. 
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